NASDAQ: AUTL - Autolus Therapeutics plc

Rentabilité sur six mois: -54.4%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Nouvelles

Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.

18 novembre 17:59 Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.